Table 5.
Effects of VIPI (differences between VIPI and TAU) on ASQ:SE/BDI after intervention (T2) and at the 6-month follow-up (T3) adjusted for ASQ:SE/BDI at baseline: B-values, confidence-intervals and p-values
| ASQ:SE T2 | ASQ:SE T3 | BDI T2 | BDI T3 | |
|---|---|---|---|---|
| B-values, 95% CI p | B-values, 95% CI p | B-values, 95% CI p | B-values, 95% CI p | |
| ASQ:SE T1 | −7.22 (−17.74 to – 3.33) | −13.79 (−25.27 to – 2.31) | ||
| 0.17 | 0.02 | |||
| BDI T1 = 15 | −0.91 (−3.44 to 1.62) | −2.64 (−5.24 to −0.04) | ||
| 0.48 | 0.047 | |||
| BDI T1 = 25 | −3.53 (−7.94 to 0.88) | −6.52 (−11.01 to −2.03) | ||
| 0.12 | 0.005 |
BDI = 15 indicate mild depressive symptoms reported by the Beck Depression Inventory; BDI = 25 indicates moderate depressive symptoms.
Bold numbers: significant differences in the level of ≤ 0.05.